MicroTech Medical (Hangzhou) Co (HKSE:02235) 5-Year EBITDA Growth Rate : 8.80% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co 5-Year EBITDA Growth Rate?

MicroTech Medical (Hangzhou) Co's EBITDA per Share for the six months ended in Dec. 2024 was HK$-0.06.

During the past 3 years, the average EBITDA Per Share Growth Rate was 0.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of MicroTech Medical (Hangzhou) Co was 32.00% per year. The lowest was 0.50% per year. And the median was 3.80% per year.

Competitive Comparison of MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

MicroTech Medical (Hangzhou) Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

MicroTech Medical (Hangzhou) Co (HKSE:02235) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

MicroTech Medical (Hangzhou) Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

Executives

Orbimed Asia Partners V, L.p.	2101 Beneficial owner
Orbimed Asia Gp V, L.p.	2201 Interest of corporation controlled by you
Orbimed Advisors V Limited	2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Ii, L.p.	2201 Interest of corporation controlled by you
Qm32 Limited	2101 Beneficial owner
Qiming Venture Partners V, L.p.	2201 Interest of corporation controlled by you
Qiming Gp V, L.p.	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.	2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Gp, L.p.	2201 Interest of corporation controlled by you
Lav Evergreen (hong Kong) Co., Limited	2101 Beneficial owner
Lav Corporate Gp, Ltd.	2201 Interest of corporation controlled by you
Zheng Pan
Cd Capital Gp Ltd	2201 Interest of corporation controlled by you
Master Summer Limited	2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd	2201 Interest of corporation controlled by you

MicroTech Medical (Hangzhou) Co Headlines

No Headlines